Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Pediatric urogenital schistosomiasis diagnosed in France

    Schistosomiasis affects approximately 230 million people worldwide. There is an increased incidence of schistosomiasis cases in France acquired from outside the country. This increases the risk of schistosomia...

    Lucas Percheron, Claire Leblanc, Tim Ulinski, Marc Fila in Pediatric Nephrology (2024)

  2. No Access

    Article

    Reversed cortico-medullary differentiation in the fetal and neonatal kidneys: an indicator of poor prognosis?

    Bilateral reversed cortico-medullary differentiation is rarely observed on fetal or neonatal renal ultrasound and is therefore a diagnostic challenge.

    Marie Cassart, Catherine Garel, Tim Ulinski, E. Freddy Avni in Pediatric Radiology (2024)

  3. No Access

    Article

    Outcome of children with IgA vasculitis with nephritis treated with steroids: a matched controlled study

    IgA vasculitis (IgAV) is the most common vasculitis in children. IgAV long-term prognosis depends on kidney involvement or IgA vasculitis with nephritis (IgAVN). To date, steroid treatment (oral steroids or me...

    Anne-Lise Mary, Stéphanie Clave, Caroline Rousset-Rouviere in Pediatric Nephrology (2023)

  4. No Access

    Article

    Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study

    Pediatric ANCA vasculitis is a rare group of diseases with a scarcity of data in children. Annual incidence appeared to increase in the last several years, placing higher interest in the clinical and therapeu...

    Sarah-louisa Mahi, Siamak Bahram, Jérôme Harambat, Lise Allard in Pediatric Nephrology (2023)

  5. No Access

    Article

    Predictive factors for survival in patients with oligohydramnios secondary to antenatal kidney disease

    Renal oligohydramnios (ROH) is caused by bilateral congenital abnormalities, either of renal parenchymal or obstructive origin. ROH is a poor prognostic factor of neonatal survival; lung hypoplasia is reported...

    Mathilde Baudin, Claire Herbez, Isabelle Guellec in Pediatric Nephrology (2023)

  6. No Access

    Article

    Benefits of BNP/NT-proBNP serum level evaluation for dry weight adjustment in pediatric hemodialysis patients

    Dry weight (DW) adjustment in children on hemodialysis (HD) can be challenging. It relies on clinical evaluation and additional supports. Our aim was to study the benefits of cardiac biomarker assessment, in a...

    Antoine Mouche, Cyrielle Parmentier, Fatma Fendri in Pediatric Nephrology (2023)

  7. No Access

    Article

    To biopsy or not to biopsy: Henoch-Schönlein nephritis in children, a 5-year follow-up study

    The prognosis of Henoch-Schönlein purpura (HSP), IgA vasculitis, depends on kidney involvement. There is no consensus on the initiation of treatment for HSP nephritis (HSPN). Some centres start treatment befor...

    Marina Avramescu, Annie Lahoche, Julien Hogan, Rémi Salomon in Pediatric Nephrology (2022)

  8. No Access

    Article

    Management of IgA Vasculitis with Nephritis

    Immunoglobulin A (IgA) vasculitis (IgAV), previously called Henoch–Schönlein purpura, is characterized by IgA-dominant immune deposits affecting small vessels and often involves the skin, gastrointestinal trac...

    Jean-Daniel Delbet, Cyrielle Parmentier, Claire Herbez Rea in Pediatric Drugs (2021)

  9. No Access

    Article

    Procalcitonin serum levels in stage 5 chronic kidney disease children on hemodialysis

    Infections are responsible for morbidity and mortality in children on hemodialysis (HD). Procalcitonin (PCT) is rarely used in this population, even though it is an efficient biomarker of infection and sepsis....

    Antoine Mouche, Cyrielle Parmentier, Claire Herbez Rea in Pediatric Nephrology (2021)

  10. No Access

    Article

    Tolvaptan therapy to treat severe hyponatremia in pediatric nephrotic syndrome

    Tolvaptan is a selective oral vasopressin V2-receptor antagonist. Some data have implicated stimulation of arginine vasopressin (AVP) as an important factor in oedema formation in a rodent model of nephrotic s...

    Jean-Daniel Delbet, Cyrielle Parmentier, Tim Ulinski in Pediatric Nephrology (2020)

  11. No Access

    Article

    Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome

    Rituximab (RTX) is efficient in steroid-dependent nephrotic syndrome (SDNS) in pediatric and adult patients. The aim of this study is to describe hypogammaglobulinemia as a side effect of RTX treatment.

    Cyrielle Parmentier, Jean-Daniel Delbet, Stéphane Decramer in Pediatric Nephrology (2020)

  12. No Access

    Article

    Histological prognostic factors in children with Henoch-Schönlein purpura nephritis

    The management of IgA vasculitis with nephritis (IgAVN) remains controversial because of the difficulty to identify prognostic factors. This study reports the prognosis of children with IgAVN in relation to hi...

    Jean-Daniel Delbet, Guillaume Geslain, Martin Auger, Julien Hogan in Pediatric Nephrology (2020)

  13. No Access

    Article

    Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome

    Chronic nephrotoxicity with potentially irreversible lesions is a major concern regarding calcineurin inhibitor (CNI) treatment in children with severe forms of idiopathic nephrotic syndrome (INS).

    Jean Daniel Delbet, Bilal Aoun, David Buob, Jad Degheili in Pediatric Nephrology (2019)

  14. No Access

    Article

    Response to “Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome”

    Tim Ulinski, Jean Daniel Delbet in Pediatric Nephrology (2019)

  15. No Access

    Article

    Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?

    Rituximab (RTX) has been shown to be an efficient treatment for steroid-dependent nephrotic syndrome (SDNS). A long B cell depletion period seems to improve the duration of remission. This study reports the du...

    Jean Daniel Delbet, Gael Leclerc, Tim Ulinski in Pediatric Nephrology (2019)

  16. Article

    Open Access

    Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report

    Levamisole belongs to the antihelminthic class of drugs that are sometimes administered to patients with frequently relapsing or steroid-dependent nephrotic syndrome, owing to its steroid-sparing effects. Neut...

    Bilal Aoun, Mohammad Alali, Jad A. Degheili, Sami Sanjad in Journal of Medical Case Reports (2018)

  17. No Access

    Article

    Thrombotic microangiopathy and breastfeeding: where is the link? Answers

    Jean Daniel Delbet, Tim Ulinski in Pediatric Nephrology (2018)

  18. No Access

    Article

    Thrombotic microangiopathy and breastfeeding: where is the link? Questions

    Jean Daniel Delbet, Tim Ulinski in Pediatric Nephrology (2018)

  19. No Access

    Article

    Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus

    Post-transplant diabetes mellitus (PTDM) is a major complication of immunosuppressive therapy, with many risk factors reported in adults with renal transplantation. The objective of this study was to investiga...

    Pauline Lancia, Tiphaine Adam de Beaumais, Valéry Elie in Pediatric Nephrology (2018)

  20. No Access

    Article

    Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome

    Familial steroid-sensitive nephrotic syndrome (SSNS) is a rare condition. The disease pathophysiology remains elusive. However, bi-allelic mutations in the EMP2 gene were identified, and specific variations in HL...

    Guillaume Dorval, Olivier Gribouval, Vanesa Martinez-Barquero in Pediatric Nephrology (2018)

previous disabled Page of 3